Form 4: Colgate-Palmolive Director Defers Retainer into Stock
Insider Transaction Report
Colgate-Palmolive Director Brian Newman acquired 238 shares of common stock at $78.66 per share through a deferred compensation plan.
Summary
- Brian Newman, a Director at Colgate-Palmolive Co. (CL), acquired 238 shares of common stock.
- The transaction occurred on January 2, 2026, at a price of $78.66 per share.
- This acquisition resulted from deferring a portion of his annual cash retainer into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors.
- Following this transaction, Newman directly holds 5,313 shares and indirectly holds 36 shares via a Family Trust.
- The transaction was made pursuant to a Rule 10b5-1(c) plan.
Sentiment
Score: 6
Explanation: The acquisition of shares by a director, even through a deferred compensation plan, generally signals confidence in the company's future prospects and aligns the director's interests with shareholders. It's a routine, non-discretionary transaction.
Positives
- A director is increasing their stake in the company, albeit through a compensation deferral, which can signal confidence.
- The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned, non-discretionary acquisition.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy Implementation | A portion of the annual cash retainer for non-employee directors is deferred into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors. | NA | This practice aligns the interests of non-employee directors with those of shareholders by increasing their equity stake in the company. |
Related Party Transactions
- Brian Newman, a director, acquired 238 shares of Colgate-Palmolive common stock at $78.66 per share as a deferral of his annual cash retainer under the company's Deferred Compensation Plan for Non-Employee Directors.
Stakeholder Impact
- Shareholders: Potentially positive, as increased director ownership can signal confidence and better alignment of interests.
Key Dates
| Date | Description |
|---|---|
| 01/02/2026 | Date of earliest transaction (acquisition of common stock) |
| 01/06/2026 | Signature date of the reporting person's attorney-in-fact |
Recommendation
holdThis Form 4 reports a routine insider transaction where a director acquired shares through a deferred compensation plan. While it indicates continued alignment of interests, it does not present new information significant enough to alter the fundamental investment thesis for Colgate-Palmolive. Therefore, a 'hold' recommendation is appropriate based solely on this filing.
Keywords
Colgate-Palmolive, CL, Insider Transaction, Form 4, Director Stock Acquisition, Deferred Compensation, Brian Newman, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.